B-cell antigens within normal and activated human T cells

Immunology

Volumn 96, Issue 3, 1999, Pages 424-433

  Sandilands, G P ^a   Perry, M ^a   Wootton, M ^a   Hair, J ^a   More, I A R ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD32 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; BIOSYNTHESIS; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CYTOPLASM VESICLE; FLOW CYTOMETRY; IMMUNOELECTRON MICROSCOPY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; ROUGH ENDOPLASMIC RETICULUM; STAINING; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; B-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CYTOPLASM; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MICROSCOPY, IMMUNOELECTRON; T-LYMPHOCYTES;

EID: 0033021604     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00692.x     Document Type: Article

References (49)

1. STAMENKOVIC I. & SEED B. (1990) The B cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature 345, 74.
2. LAW C.L., SIDORENKO S.P. & CLARK E.A. (1994) Regulation of lymphocyte activation by the cell-surface molecule CD22. Immunol Today 15, 442.
3. CAMPANA D., THOMSON J.S., AMLOT P., BROWN S. & JANOSSY G. (1987) The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage. J Immunol 138, 648.
4. FEARON D.T. & AHEARN J.M. (1990) Complement receptor type-1 (C3b, C4b receptor CD35): and complement receptor type 2 (C3d, EBV-R-CD21). Curr Top Microbiol Immunol 153, 83.
5. JOST C.R., DE GOEDE R., FRANSEN J.A., DAHA M.R. & GINSEL L.A. (1991) On the origin of FcγRIII (CD16)-containing vesicle population in human neutrophil granulocytes. Eur J Cell Biol 54, 313.
6. MELLMAN I., PLUNTER H. & UKKONEN P. (1984) Internalization and rapid recycling of macrophage Fc receptors tagged with monocovalent anti-receptor antibody: possible role of a pre-lysosomal compartment. J Cell Biol 8, 1170.
7. CRESSWELL, P. (1996) Invariant chain structure and MHC class II function. Cell 84, 505.
8. SCHROFF R.W., BUCANA C.D., KLEIN R.A., FARREL M.M. & MORGAN A.C. JR (1984) Detection of intracytoplasmic antigens by flow cytometry. J Immunol Methods 70, 167.
9. MORGAN, A.C. JR, SCHROFF R.W., KLEIN R.A. et al. (1986) Occult (non-surface expression) of T, B and monocyte markers in human large granular lymphocytes. Eur J Immunol 335, 117.
10. SANDILANDS G.P., MCLAREN A.P., HOWIE D. & MACSWEEN R.N.M. (1995) Occult expression of CD32 (FcγRII) in normal human peripheral blood mononuclear cells. Immunology 86, 525.
11. SANDILANDS G.P., MACPHERSON S.A., BURNETT E.R., RUSSELL A.J., DOWNIE I. & MACSWEEN R.N.M. (1997) Differential expression of CD32 isoforms following alloactivation of human T cells. Immunology 91, 204.
12. HALLDEN G., ANDERSSON U., HED J. & JOHANSSON S.G. (1989) A new membrane permeabilisation method for the detection of intracellular antigens. J Immunol Methods 124, 103.
13. JACOB M.C., FAVRE M. & BENSA J.C. (1991) Membrane cell permeabilisation with saponin and multiparametric analysis by flow cytometry. Cytometry 12, 550.
14. POLLICE A.A., MCCOY J.P., SHACKNEY S.E., SMITH C.A. et al. (1992) Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins. Cytometry 13, 432.
15. PIZZOLO G., VINCENZI C., NADALI G., VENERI D. et al. (1994) Detection of membrane and intracellular antigens by flow cytometry following ORTHO PermeaFix fixation. Leukaemia 8, 672.
16. FRANCIS C. & CONNELLY M.C. (1996) Rapid single-step method for flow cytometric detection of surface and intracellular antigens using whole blood. Cytometry 25, 58.
17. + T lymphocytes that express Fc receptors for IgG (CD16/leu 11a). J Exp Med 162, 2089.
18. TSOUKAS C.D. & LAMBRIS J.D. (1988) Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur J Immunol 18, 1299.
19. FISCHER E., DELIBRIAS C. & KAZATCHKINE M.D. (1991) Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 146, 865.
20. DELIBRIAS C.C., FISCHER E., BISMUTH G. & KAZATCHKINE M.D. (1992) Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL. J Immunol 149, 768.
21. HULTIN L.E., HAUSNER M.A., HULTIN P.M. & GIORGI J.V. (1993) CD20 (pan-B cell) antigen is expressed at low level on a subpopulation of human T lymphocytes. Cytometry 14, 196.
22. BAUDEAU C., FALKENRODT A., PARISSIADIS A. & TONGIO M.M. (1993) A significant percentage of normal T lymphocytes express HLA-DP in the peripheral blood. Tissue Antigens 42, 111.
23. DELIBRIAS C.C., MOUHOUB A., FISCHER E. & KAZATCHKINE M.D. (1994) CRI (CD35) and CR2 (CD21) complement C3 receptors are expressed on normal thymocytes and mediate infection of thymocytes with opsonised human immunodeficiency virus. Eur J Immunol 24, 2784.
24. SANDOR M., GALON J., TAKACS L., TATSUMI Y. et al. (1994) An alternative Fc gamma-receptor ligand: potential role in T-cell development. Proc Natl Acad Sci USA 91, 12857.
25. LECLERCQ G. & PLUM J. (1995) Expression and function of Fc receptors in the thymus. Crit Rev Immunol 15, 215.
26. YU D.T.Y., WINCHESTER R.J., FU S.M., GIBOFSKY A., KO H.S. & KUNKEL H.G. (1980) Peripheral blood Ia-positive T cells. J Exp Med 151, 91.
27. MATSUI Y., SHAPIRO H.M., SHEEHY M.J., CHRISTENSON L. et al. (1986) Differential expression of T cell differentiation antigens and major histocompatability antigens on activated T cells during the cell cycle. Eur J Immunol 16, 248.
28. LEVY E., AMBRUS J., KAHL L., MOLINA H. et al. (1992) T lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE). Clin Exp Immunol 90, 235.
29. ENGELHARDT W., MATZKE J. & SCHMIDT R.E. (1995) Activation-dependent expression of low affinity IgG receptors Fc gamma II (CD32) and Fc gamma RIII (CD16) in subpopulations of human T lymphocytes. Immunobiology 192, 297.
30. RODGAARD A., THOMSEN B.S., BENDIXEN G. & BENTDZEN K. (1995) Increased expression of complement receptor type 1 (CR1, CD35) on human peripheral blood T lymphocytes after polyclonal activation in vitro. Immunol Res 14, 69.
31. + T cell lines. Cell Immunol 163, 139.
32. WEYAND C.M., JENDRO M. & GORONZY J.J. (1991) Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders. Autoimmunity 8, 281.
33. BARNABA V., WATTS C., DE BOER M., LANE .P. & LANZAVECCHIA A. (1994) Professional presentation of antigen by activated human T cells. Eur J Immunol 24, 71.
34. WESTHOFF. U., THINNES P., GOTZ H. & GROSSE-WILDE H. (1991) Quantilation of soluble HLA Class II molecules by an enzyme-linked immunosorbent assay. Vox Sang 61, 106.
35. HAUSMANN S., CLAUS R., BUCHWALD S., KOHLER H. et al. (1994) Quantitation of soluble HLA-DR antigens in human serum and other body fluids. Beitr Infusionsther Transfusionmed 32, 281.
36. FREMEUX-BACCHI V., FISCHER E. & KAZATCHKINE M.D. (1996) Membrane and soluble forms of CD21 (the C3dg/EBV receptor). Immunol Lett 54, 210.
37. FRIDMAN W.H. (1993) Regulation of B cell activation and antigen presentation by Fc receptors. Curr Opin Immunol 5, 35.
38. PASCUAL M., DUCHOSAL M.A., STEIGER G., GIOSTRA E. et al. (1993) Circulating soluble CR1 (CD35). Serum levels in disease and evidence for its release by human leukocytes. J Immunol 151, 1702.
39. DANIELSSON C., PASCUAL M., FRENCH L., STEIGER I. & SCHIFFERLI J.A. (1994) Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage. Eur J Immunol 24, 2725.
40. HARA T., FUKUDA H., MASSAOKA T., MATSUMOTO M. & SEYA T. (1994) Development of an ELISA assay for soluble CD35 (C3b/C4b receptor): high levels of soluble CD35 in LE-positive patients with haematological malignancies. Immunol Lett 41, 249.
41. FILACI G., CONTINI P., BRENCI S. et al. (1995) Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation. Tissue Antigens 46, 117.
42. LARCHER C., KEMPKES B., KREMMER E., PRODINGER W.M. et al. (1995) Expression of Epstein Barr virus nuclear antigen-2 (EBNA 2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21. Eur J Immunol 25, 1713.
43. ASTIER A., MERLE-BERAL H., DE LA SALLE MONCUIT J. et al. (1997) Soluble Fc gamma receptor, Fc gamma RIIa2, is present in two forms in human serum and is increased in patients: with stage C chronic lymphocytic leukaemia. Leuk Lymphoma 26, 317.
44. ZIER K., GANSBACHER B., IKEGAKI N., KENNET R. & POLAKOVA K. (1989) Expression of HLA-DR mRNA in T cells following activation is early and can precede DNA synthesis. Autoimmunity 5, 59.
45. CAPLEN H.S., SALVADORI S., GANSBACHER B. & ZIER K.S. (1992) Post-transcriptional regulation of MHC class II expression in human T cells. Cell Immunol 139, 98.
46. BRAUN M., MELCHERS I., PETER H.H. & ILLGES H. (1998) Human B and T lymphocytes have similar amounts of CD21 mRNA, but differ in surface expression of the CD21 glycoprotein. Int Immunol 10, 1197.
47. KAMOUN M., ZERVA L., SLOAN S., ZMUEWSKI C. et al. (1992) Induction of HLA Class II molecules on human T cells: relationship to immunoregulation and the pathogenesis of AIDS. DNA Cell Biol 11, 265.
48. GUERY J.C. & ADORINI L. (1993) Selective Immunosuppression of class II-restricted T cells by MHC Class II binding peptides. Crit Rev Immunol 13, 195.
49. LASALLE J.M., OTA K. & HAFLER D.A. (1991) Presentation of autoantigen by human T cells. J Immunol 147, 774.